X-ray crystallography

Derek Mendez and Xueli “Sherry” Zheng aim to accelerate drug discovery and improve energy storage.

X-rays unveil new molecular structure details that will help researchers design novel drug therapies to address antibiotic resistant bacteria.

Oxidizing chemicals break this cellular power plant into useless bits, leading to  Parkinson’s disease, ALS, heart disease, diabetes, cancer and more. A small molecule could block the process.

The new findings highlight the need for ongoing monitoring of H5N1’s evolution in nature. 

For nearly 50 years, Hodgson has illuminated the synchrotron radiation community through his pioneering research, innovations, leadership, advocacy and mentorship at the Stanford Synchrotron Radiation Lightsource.

The high-energy upgrade will keep the U.S. at the forefront of X-ray science and technology, allowing researchers to advance fields such as sustainability, human health and quantum information.

The results, which show how the protein adds nucleotides to the growing RNA chain, could lead to more effective medications.

Wheat and other sources of gluten can spell trouble for people with the disease, but new findings could aid the development of first-ever drugs for the autoimmune disorder.

Scientists at Stanford and NYU have published and investigated a new structure of the protein LAG-3 which could enable the development of new cancer treatments.

Teams at SLAC installed new experimental hutches with cutting-edge instruments that will harness the upgraded facility’s new capabilities and expand the breadth of research done at the facility.

A   swap of metals and a mutation ramp up the electric field strength at the active site of an enzyme, making it   works an astonishing 50 times faster than its unmodified analog.  

An international team has uncovered details about the formation of DNA's building blocks, paving the way  for potential medical and therapeutic applications.